Skip to main content
Ingredients/Probiotic/Lacticaseibacillus casei R0215

Lacticaseibacillus casei R0215.

A well-characterized probiotic strain that supports digestive and immune health. Supports digestive function and immune health by colonizing the gut, producing lactic acid, and competing with harmful bacteria for resources.

PromisingResearch strength1 to 10 CFUDaily amount

Reviewed March 2026

LCProbiotic
Lacticaseibacillus casei R0215IngredientMD
Category
Probiotic

Also filed under
Digestive healthImmune supportDiarrhea preventionLactose digestion

What Lacticaseibacillus casei R0215 is, and what it does.

Does it work
Solid probiotic with species-level evidence. The R0215 strain is well-characterized for stability and survival. Good as part of a multi-strain formula.
How much to take
1-5 billion CFU daily. Higher doses (10-20 billion) aren't harmful but don't necessarily work better for most people. L. casei species is well-studied at these ranges.
Time to feel it
Digestive changes usually show up within one to two weeks of daily use. A steadier bowel pattern tends to settle by about week four.
The first dose
Mild digestive adjustment is possible. Some people notice slight gas or changed stool consistency as the new bacteria settle in. Most people feel nothing.
With regular use
By week 3-4, digestive regularity typically improves. Immune benefits build gradually over 8-12 weeks of consistent use.
How well tolerated
Excellent safety record. L. casei has decades of safe use in food and supplements. Only concern is for severely immunocompromised individuals who should check with their doctor first.
How it feels
Subtle. You might notice fewer digestive complaints, slightly more consistent bowel habits. It's the kind of thing where you realize it was helping after you stop.
The overlooked benefit
The lactate it makes is eaten by other colonic bacteria and turned into butyrate, so it feeds a fuel supply for the gut lining that it never makes itself.

1 to 10 CFU a day is where Lacticaseibacillus casei R0215 works.

How much to take a dayMedium confidence
1 to 10 CFU
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
20,000,000,000 CFUClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
MORE EFFECT ↑05,000,000,000 CFU20,000,000,000 CFU plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: L. casei meta-analyses; Lallemand R0215 strain documentation

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

  • Supports digestive health
  • Enhances immune function
  • Survives gastric passage
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.

Questions people ask about Lacticaseibacillus casei R0215.

What's the difference between this and regular L. casei?
R0215 is a specific strain number from Lallemand. It means this particular strain has been characterized for gastric survival and shelf stability. Generic 'L. casei' could be any strain.
Do I need to refrigerate it?
R0215 was specifically selected for shelf stability, so room temperature storage is fine for sealed products. Once opened, refrigeration extends potency.
Can I take this with antibiotics?
Yes, and it might actually help. Space them 2 hours apart so the antibiotic doesn't kill the probiotic immediately. Several studies show L. casei reduces antibiotic-associated diarrhea.
How long until I notice a difference?
Most people report digestive improvements within 2-4 weeks. If you don't notice anything after 6 weeks, this particular strain may not be the right fit for your microbiome.
Is this the same as what's in Yakult?
Same species (L. casei) but different strain. Yakult uses L. casei Shirota. R0215 is Lallemand's strain. Both are well-characterized but not identical.
Why did the name change from Lactobacillus?
In 2020, scientists split the old Lactobacillus genus into 25 new genera based on DNA analysis. L. casei became Lacticaseibacillus casei. Same bacterium, just a more accurate scientific name.
Pairs well with29 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Lacticaseibacillus casei R0215 + Inulin (Chicory Root)fermentable substrate for lactobacilli

Inulin passes the small intestine intact and is fermented by lactobacilli to lactate and short-chain fatty acids. Pairing strain and substrate is the standard synbiotic construction.

Lactobacilli carry beta-fructofuranosidase and take up short-chain fructans readily, so FOS is fermented in the proximal colon. It is the shortest-chain version of the same substrate class as inulin.

Lactic acid bacteria hydrolyse galactooligosaccharides with the same beta-galactosidase they use on lactose. That gives the strain a substrate it is already equipped to ferment.

Lacticaseibacillus casei R0215 + Resistant Starchcross-feeding into butyrate producers

Resistant starch is fermented largely by primary degraders whose lactate and acetate feed butyrate producers, and lactobacilli contribute lactate to the same pool. The combination shifts fermentation further along the colon.

Lacticaseibacillus casei R0215 + PHGG (Sunfiber)slow-fermenting soluble fibre substrate

Partially hydrolysed guar ferments gradually across the colon rather than all at once, which extends substrate availability for a lactate-producing strain.

Lactate and acetate from a Lacticaseibacillus strain are substrates that bifidobacteria and downstream butyrate producers use. Pairing the genera keeps the fermentation chain moving rather than accumulating lactate.

Lacticaseibacillus casei R0215 + Butyratefermentation end product supplied directly

Lactate from this strain is converted to butyrate only when the right cross-feeding bacteria are present. Supplying butyrate covers the same endpoint when that step is limited.

Lacticaseibacillus casei R0215 + Lactobacillus AcidophilusStandard multi-strain co-formulation across different colonisation niches

Acidophilus favours the small intestine while casei group organisms tolerate a wider range of conditions and are recovered further along the tract, so the two occupy different parts of the same gut. Multi-strain products are built on that division of niches. Benefit is strain-specific and combination data does not transfer from one blend to another.

Lacticaseibacillus casei R0215 + Lactobacillus PlantarumComplementary fermentative and adhesion profiles in a blend

Plantarum strains are unusually bile-tolerant and carry a broad carbohydrate utilisation range, which overlaps only partly with the casei group. Blending widens the substrate range the product can act on. Whether a specific pair does more than either alone has to be measured for that pair.

Lacticaseibacillus casei R0215 + Bifidobacterium LactisLactobacillus plus Bifidobacterium is the conventional pairing across gut regions

Bifidobacteria dominate the colon while lactobacilli are more prominent in the small intestine, so pairing the genera covers more of the tract than either does alone. B. lactis is also among the most acid- and bile-tolerant bifidobacteria, which suits it to a combined product. Effects remain strain-specific.

Lacticaseibacillus casei R0215 + Saccharomyces BoulardiiA yeast and a bacterium occupy different ecological positions

S. boulardii is a yeast, so it is not affected by antibacterial agents and does not compete for the same adhesion sites or substrates as a lactobacillus. That independence is the usual reason to combine them. It also means the two behave separately rather than reinforcing each other in any specific pathway.

Lacticaseibacillus casei R0215 + LactaseBoth hydrolyse lactose, by enzyme and by fermentation

Supplemental beta-galactosidase splits lactose in the small intestine before it reaches the colon, while lactic acid bacteria ferment whatever lactose arrives there. The two act at different points on the same substrate. Lactase acts within minutes of a dose. A bacterial contribution depends on viable delivery.

Lacticaseibacillus casei R0215 + Beta-Glucan OatFermentable viscous fibre reaching the colon intact

Oat beta-glucan is not digested by human enzymes and is fermented by colonic bacteria to short-chain fatty acids. That gives resident and supplemented lactic acid bacteria substrate to work with. It is a general fermentation substrate rather than a selective one for this strain.

Lacticaseibacillus casei R0215 + PectinFermentable soluble fibre feeding lactic acid bacteria

Pectin is fermented in the proximal colon and its degradation products support lactate- and acetate-producing organisms. Pairing it with a supplemented strain supplies substrate at the point of arrival. Pectin ferments readily, which is also why a large dose produces gas.

Lacticaseibacillus casei R0215 + GlucomannanViscous polysaccharide with partial colonic fermentation

Konjac glucomannan is fermented by colonic bacteria after acting as a viscous bulking fibre higher up. That gives it a substrate role alongside its physical one. Fermentability data is more limited than for inulin or pectin, so this stays early.

Lacticaseibacillus casei R0215 + PsylliumPartly fermentable gel-forming fibre

Psyllium is only partially fermented, which is why it retains its gel through the colon and acts more as a bulking and stool-normalising agent than as a fermentation substrate. It still supplies some material to the microbial community. Its main effect on stool is physical, not microbial.

Lacticaseibacillus casei R0215 + LactoferrinIron sequestration that favours lactic acid bacteria over iron-dependent organisms

Lactoferrin binds free iron tightly, and most lactobacilli are among the few bacteria that do not require iron for growth, so withdrawing free iron disadvantages competitors more than it disadvantages the supplemented strain. That is the documented selective rationale for combining the two. It is a mechanism from microbiology rather than a measured clinical combination.

Lacticaseibacillus casei R0215 + Colostrum BovineImmunoglobulins and oligosaccharides delivered alongside a live strain

Bovine colostrum supplies immunoglobulin G, lactoferrin and milk oligosaccharides, and the oligosaccharide fraction is fermentable by bifidobacteria and some lactobacilli. Products combine it with live strains on that basis. Human combination evidence is limited.

Lacticaseibacillus casei R0215 + ZincZinc is required for enterocyte tight junction protein expression

Zinc deficiency measurably loosens intestinal tight junctions in animal and cell work, and zinc-dependent enzymes are needed for normal epithelial turnover. A live strain that acts partly by supporting barrier function is working on the same structure zinc maintains. The two support barrier integrity from different sides and have not been trialled together here.

Lacticaseibacillus casei R0215 + Zinc CarnosineBarrier-directed complex alongside a barrier-directed strain

Zinc carnosine adheres to mucosal surfaces in animal work and is used for that localised barrier rationale rather than as a general zinc source. It overlaps in intent with a strain selected for barrier support. Evidence is mostly preclinical and no combination has been studied.

Lacticaseibacillus casei R0215 + L-GlutaminePreferred fuel of the enterocyte

Glutamine is the main respiratory substrate for small intestinal enterocytes, while butyrate from bacterial fermentation fuels the colonocyte. A live strain contributing to colonic fermentation and a glutamine dose therefore feed different segments of the same epithelium. Complementary by mechanism, untested as a pair.

Lacticaseibacillus casei R0215 + Vitamin D3Vitamin D receptor signalling in intestinal epithelium and immune cells

The vitamin D receptor is expressed in intestinal epithelium and in dendritic cells and T cells, and its signalling influences tight junction protein expression and antimicrobial peptide production. Those are the same host pathways a live strain engages through pattern recognition receptors. The overlap is at the level of host signalling. The pairing has not been measured.

Lacticaseibacillus casei R0215 + FolateSeveral lactic acid bacteria synthesise folate in the gut lumen

Folate biosynthesis is documented in a number of lactic acid bacteria and is exploited deliberately in fermented dairy production. Whether a given strain is a net producer or a net consumer of folate is strain-specific and has to be measured. Supplemental folate covers requirement regardless of what the strain does.

Lacticaseibacillus casei R0215 + Vitamin B2 RiboflavinRiboflavin biosynthesis occurs in some lactic acid bacteria

Riboflavin-overproducing lactic acid bacteria have been isolated and used to biofortify fermented foods, so the biosynthetic capacity exists in this group. It is a strain-level trait, not a genus-level one, and cannot be assumed for a specific product. Dietary riboflavin remains the reliable source.

Lacticaseibacillus casei R0215 + Betaine HClLowering gastric pH works against viable transit through the stomach

Gastric acid is the main barrier a swallowed live strain has to survive, and betaine hydrochloride is taken specifically to lower stomach pH. Taking the two in the same swallow raises the acid challenge at the worst moment. Separating them, or using an acid-protective capsule, avoids the conflict.

Lacticaseibacillus casei R0215 + Activated CharcoalNon-selective adsorption of co-ingested material

Activated charcoal adsorbs a wide range of organic molecules and particulates without selectivity, which is exactly why it is used as an adsorbent. Anything taken in the same window, including a live culture and its protective matrix, is subject to that adsorption. Spacing by two hours or more is the standard practice.

Lacticaseibacillus casei R0215 + Bentonite ClayAdsorptive clay taken with a live culture

Bentonite binds cations and organic material through its layered aluminosilicate structure and is taken as a gut adsorbent. Co-timing with a live strain works against delivering that strain intact. The timing point is general to adsorbents rather than specific to this clay.

Lacticaseibacillus casei R0215 + Digestive EnzymesFormulation practice of pairing enzymes with live cultures

Protease, amylase and lipase blends act in the upper tract on macronutrients, while a live strain acts further down. The two are combined because they address different stages of digestion in one capsule. A protease-heavy blend and a live culture in the same capsule is a formulation question about protein integrity, and manufacturers separate them for that reason.

Lacticaseibacillus casei R0215 + Green Tea Extract EGCGPolyphenols are antibacterial in vitro at high concentration

Catechins inhibit growth of a range of bacteria in culture, with lactic acid bacteria generally less affected than gram-negative organisms, and polyphenols are also fermented by gut bacteria into active metabolites. The direction of the net effect in a person depends on dose and on the strain. Not enough to call it additive or competitive with confidence.

Who should be cautious

Talk to a doctor before taking Lacticaseibacillus casei R0215 if any of these apply to you: May cause initial gas/bloating. These are flags to check first, not effects Lacticaseibacillus casei R0215 is known to cause.

Not medical advice. Show the label to your pharmacist.

What Lacticaseibacillus casei R0215 actually does.

Established

This is a lactic acid bacterium that can ferment sugars by more than one route. Its genus name moved from Lactobacillus in the 2020 reclassification of the Lactobacillaceae, so older papers on the same organism read Lactobacillus casei.

Established

Its main output is lactic acid from fermenting carbohydrate, which drops the pH nearby. That local acidity is the basis of the competitive exclusion effect people attach to lactic acid bacteria.

Established

Probiotic behaviour is a strain trait. Two strains of one species can differ in acid and bile tolerance, in how they adhere, and in immune signalling. So a designation like R0215 is part of the identity rather than a marketing detail.

Established

Stomach acid and bile salts are the two barriers a swallowed strain has to survive. Measured survival comes down to the strain, the delivery matrix, and whether the dose goes down with food that buffers stomach pH.

Grown by microbes, 7 steps on record

Where Lacticaseibacillus casei R0215 comes from.

The strain is grown from a stored seed culture in a controlled tank, then separated from the liquid it grew in, mixed with protective sugars, and freeze dried into a powder. The protective sugars and how dry the powder ends up are what keep the bacteria alive on the shelf, and each batch is counted and identity-checked before it is filled.

Produced by a cultured organism rather than harvested. The strain is selected and the conditions are controlled, so batches sit closer together than a field crop.

Starts as
Working seed culture from a strain bank

Production starts from a cryopreserved master cell bank of the specific R0215 isolate, expanded through a working bank so that every commercial lot traces to the same deposited strain rather than to a re-isolated organism.

Converted by
Controlled fermentation

The culture is grown in a stirred vessel on a nitrogen and carbohydrate medium, typically dairy- or yeast-extract based, with pH held in the mildly acidic range by base addition because the organism acidifies its own medium and would otherwise arrest its growth.

Extracted by
Harvest and concentration

Cells are separated from spent medium by centrifugation or membrane filtration and washed, which concentrates biomass and removes most of the fermentation metabolites and residual medium.

Purified by
Cryoprotectant addition

The concentrate is blended with protective sugars and polyols such as trehalose, sucrose or glycerol, which replace bound water at the cell membrane and are what allow a large fraction of cells to survive the drying step.

Converted by
Freeze drying

The protected concentrate is frozen and then dried by sublimation under vacuum to a low residual moisture, since water activity is the single variable that most governs how quickly viability falls during storage.

Standardised to
Enumeration and identity confirmation

Viable count is measured by plate count or flow cytometry and the powder is diluted with a carrier to a declared colony forming units per gram. Strain identity is confirmed by molecular typing, and purity, gastric and bile survival, and shelf-stability checks are run on the lot.

Ends up as
Blending, filling and cold-chain packing

The standardised powder is blended, encapsulated or filled under controlled low humidity, with an overage set against the measured decay rate so the count still meets label at the end of shelf life, then packed with a desiccant and shipped cool.

Getting Lacticaseibacillus casei R0215 from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Aged cheese (Cheddar, Parmesan)Fermented vegetables

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

L. casei R0215, lyophilisedCells are frozen with a cryoprotectant such as trehalose or sucrose and dried under vacuum, leaving a low-moisture powder in which metabolism is arrested and viability decays slowly.Fits Capsules, sachets, and blending into other powders where a stated viable count per gram is required.Trade-off Viability declines over shelf life at a rate governed by moisture and temperature, so the count depends on storage and on whether the label figure is at manufacture or at expiry.
Acid-protected L. casei R0215The same lyophilised powder inside a pH-responsive capsule or coating that stays closed at gastric pH and opens in the small intestine.Fits Dosing away from food, where the buffering a meal provides is not available.Trade-off The coating adds volume that displaces powder in a fixed capsule size, and the release point depends on gastric emptying and on the individual's pH, which vary.Active and formulation aid
L. casei R0215 in a cultured dairy baseThe strain is delivered in the milk it was grown in, so the dose arrives with milk protein, lactose and the fermentation metabolites produced in situ.Fits Drinks and cultured foods, where the dairy buffers gastric acid and the format needs no capsule.Trade-off Requires refrigeration, has a short shelf life relative to a dried powder, and is not suitable for anyone avoiding dairy.
L. casei R0215 in a defined blendA fixed-ratio combination with other named strains, each with its own count, where the label total is the sum across strains.Fits Products aiming at more than one gut region or more than one mechanism in a single serving.Trade-off A blend total does not say how much of any one strain is present, and evidence generated for a single strain does not carry over to a blend that includes it.Active and formulation aid

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.

On the shelf

What Lacticaseibacillus casei R0215 comes in.

Products in our catalog that carry it, read the same way every product here is read.